Connect your AI

BBNX BBNX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Tandem Diabetes CareTNDM

5.7%0.0pp

AdaptHealthAHCO

$122.97M+23.4%

Halozyme TherapeuticsHALO

——

Other financials

Income statement

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BBNX's operating lease ROU assets?: BBNX (BBNX) reported operating lease ROU assets of $6.23M in Q1 2026.
How has BBNX's operating lease ROU assets changed year-over-year?: BBNX's operating lease ROU assets decreased by 1.9% year-over-year, from $6.34M to $6.23M.
What is the long-term trend for BBNX's operating lease ROU assets?: Over 2 years (2023 to 2025), BBNX's operating lease ROU assets has grown at a 33.4% compound annual growth rate (CAGR), from $3.72M to $6.63M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.